Inovio Pharma (INO) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.12 --0%
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
UBAB, LOAN, FITB, More
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.10), $0.13 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $103 million versus the consensus estimate of $217.65 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- VIST Financial Corp. (VIST) Misses Q2 EPS by 76c
- JPMorgan upgrades 3M, Emerson Electric to Overweight ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
